FLOW Trial and Semaglutide's Benefit in Chronic Kidney Disease

To celebrate the FLOW trial and break down what it means for people with type 2 diabetes and CKD, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, recorded a special edition episode to discuss the clinical application of this trial, unmet need in CKD management, the future of incretin therapies, and more!



Chapters:

00:00 - Intro 

00:40 - FLOW Background

02:55 - FLOW Results

07:08 - Combination with SGLT2 Inhibitors

12:00 - Future Implications